Prognostic value of XXXX in @entity1 undergoing allogeneic bone marrow transplantation after conditioning with @entity348 .

@entity6708 @entity1 @entity8262 @entity348 @entity842
This study was performed to investigate whether measurement of @entity8262 ( @entity6708 ), a marker for @entity842 production, before and after allogeneic bone marrow transplantation (BMT) with @entity348 ( @entity348 ) conditioning was of prognostic value. @entity6708 levels were monitored in 23 consecutive @entity1 who received @entity348 as conditioning for BMT, and were compared with the outcome. @entity6708 became positive during the aplastic phase after BMT in 12 @entity1 . In nine of these 12 @entity1 , @entity6708 level decreased during the recovery phase. Eight of the nine @entity1 survived, one dying after relapse. In three other @entity1 , the @entity6708 level continued to increase even during the recovery phase and they died of severe complications. @entity6708 became positive on day 0 of BMT and during the leukocyte recovery phase after BMT in two and seven of the 23 @entity1 , respectively. Subsequently, all @entity1 died of severe complications. The two @entity1 who were negative for @entity6708 both before and after BMT survived without complications. These results suggest that monitoring @entity6708 from early after BMT may be useful for predicting outcome and that it may be a useful prognostic marker.
